FDA — authorised 5 April 2010
- Application: NDA022272
- Marketing authorisation holder: PURDUE PHARMA LP
- Status: supplemented
FDA authorised Oxycodone HCl on 5 April 2010
Yes. FDA authorised it on 5 April 2010.
PURDUE PHARMA LP holds the US marketing authorisation.